服用他类药物的患者患有拉布地质溶解的风险增加:基于人口的病例对照研究
Ya-Wen Lu1, Jong-Yi Wang2, Heng-Jun Lin3
1Pharmaceutical Department, Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan.
Therapeutic advances in drug safety
|August 13, 2025
概括
静止剂的使用增加了拉布多米解症的风险,特别是在患有精神疾病的患者中. 对于处方他类药物的患者来说,以减轻不良影响,必须进行仔细监测.
科学领域:
- 药物监督 药物监督 药物监督
- 临床流行病学临床流行病学
- 药品安全 药品安全
背景情况:
- 类他类药物对于降低高风险个体的心血管事件至关重要.
- 达丁类药物诱导的肌肉毒性是不耐受和停止治疗的重要原因.
- 关于他类药物使用与骨髓溶解风险之间的关联存在有限的研究.
研究的目的:
- 为了比较使用他类药物的患者与不使用他类药物的患者的狂肌溶解风险.
- 为了确定拉布地质溶解的独立风险因素.
- 为了调查使用他类药物和精神疾病的综合风险,在rhabdomyolysis.
主要方法:
- 使用台湾国家健康保险研究数据库 (2011-2020) 进行了基于人口的病例控制研究.
- 186,604名拉布多结症患者 (病例) 与746,416名对照人群进行了匹配.
- 在这两组中,评估了类固醇药物的使用和其他潜在的风险因素.
主要成果:
- 达丁类药物使用者具有显著更高的狂犬病溶解风险 (调整后OR:1.70,95%CI:1.68-1.73).
- 精神疾病,,热中风和压伤被确定为独立的危险因素.
- 使用他类药物的精神疾病患者面临增加的风险 (调整后OR: 2.30,95%CI: 1.95-2.71).
结论:
- 达丁类药物的使用与拉布多溶解的风险增加有关.
- 在患有同时出现精神疾病的患者中,风险显著增加.
- 临床医生必须对他类药物使用者,特别是那些患有精神疾病的人群的狂犬病保持警,需要主动监测和风险评估.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
871
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
871
01:24Nephrotic Syndrome I : Introduction
27
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
27
01:09Hepatic Drug Clearance: Effect of Protein Binding
285
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
285
01:29Cholesterol: Significance and Regulation
686
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
686
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
114
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
114
01:24Chronic Kidney Disease II: Clinical Manifestations
91
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
91